{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nVyas P. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDiNardo CD. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S249 - S250
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDaver N. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S253 - S254
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSallman DA. et al, (2022), AMERICAN JOURNAL OF HEMATOLOGY, 97, S20 - S21
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSallman D. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S314 - S315
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nChen J. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S317 - S318
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSternberg A. et al, (2022), Br J Haematol, 199, 222 - 229
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nJackson TR. et al, (2022), iScience, 25
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSymeonidou V. et al, (2022), EJHaem, 3, 794 - 803
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nArber DA. et al, (2022), Blood
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nde Botton S. et al, (2022), Blood
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSchenck RO. et al, (2022), CANCER RESEARCH, 82
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSekeres MA. et al, (2022), Ann Hematol
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPerl AE. and Vyas P., (2022), Clin Cancer Res
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nVyas P., (2022), Cell Stem Cell, 29, 184 - 186
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nVyas P. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S247 - S247
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nLachowiez C. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S240 - S241
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nFreeman SD. et al, (2022), BLOOD, 140
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver N. et al, (2022), BLOOD, 140
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLoke J. et al, (2022), Br J Haematol, 196, 368 - 373
\n \n \n \n\n \n
\n \n \n